SG11201907124YA - Anti-inflammatory agent - Google Patents

Anti-inflammatory agent

Info

Publication number
SG11201907124YA
SG11201907124YA SG11201907124YA SG11201907124YA SG11201907124YA SG 11201907124Y A SG11201907124Y A SG 11201907124YA SG 11201907124Y A SG11201907124Y A SG 11201907124YA SG 11201907124Y A SG11201907124Y A SG 11201907124YA SG 11201907124Y A SG11201907124Y A SG 11201907124YA
Authority
SG
Singapore
Prior art keywords
inflammatory agent
active ingredient
liver hydrolysate
inflammatory
agent
Prior art date
Application number
SG11201907124YA
Other languages
English (en)
Inventor
Kotaro Yamada
Hidetomo Sakurai
Michio Komai
Hitoshi Shirakawa
Keisuke Nakamura
Puspo Edi Giriwono
Kazuma Ueda
Original Assignee
Zeria Pharmaceutical Co Ltd
Univ Tohoku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharmaceutical Co Ltd, Univ Tohoku filed Critical Zeria Pharmaceutical Co Ltd
Publication of SG11201907124YA publication Critical patent/SG11201907124YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/28—Substances of animal origin, e.g. gelatin or collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/204—Animal extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201907124YA 2017-02-23 2018-02-22 Anti-inflammatory agent SG11201907124YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017032541 2017-02-23
PCT/JP2018/006351 WO2018155525A1 (ja) 2017-02-23 2018-02-22 抗炎症剤

Publications (1)

Publication Number Publication Date
SG11201907124YA true SG11201907124YA (en) 2019-09-27

Family

ID=63253284

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201907124YA SG11201907124YA (en) 2017-02-23 2018-02-22 Anti-inflammatory agent
SG10202108899XA SG10202108899XA (en) 2017-02-23 2018-02-22 Anti-inflammatory agent

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10202108899XA SG10202108899XA (en) 2017-02-23 2018-02-22 Anti-inflammatory agent

Country Status (6)

Country Link
JP (1) JP7216966B2 (ja)
KR (1) KR102608239B1 (ja)
CN (1) CN110198723B (ja)
SG (2) SG11201907124YA (ja)
TW (1) TWI794210B (ja)
WO (1) WO2018155525A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7795731B2 (ja) * 2018-04-26 2026-01-08 ゼリア新薬工業株式会社 ジペプチドを含有する医薬組成物
JP7261590B2 (ja) * 2019-01-21 2023-04-20 和三郎 佐藤 神経機能再生促進剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3272743B2 (ja) * 1991-04-26 2002-04-08 三省製薬株式会社 安定なｓｏｄ活性を有する胎盤または肝臓抽出液およびそれを含有する外用剤組成物
KR20020086500A (ko) * 2000-02-08 2002-11-18 에스에스 세야쿠 가부시키 가이샤 리간드 또는 리간드 양태의 저분자 화합물의 검출 방법
JP4988085B2 (ja) 2000-09-04 2012-08-01 ハウスウェルネスフーズ株式会社 肝機能賦活剤
EP1356810A4 (en) * 2000-12-27 2005-02-02 Ajinomoto Kk TNFα PRODUCTION INHIBITORS
CA2608651A1 (en) * 2005-05-24 2006-11-30 Wellgen, Inc. Compositions and methods for the prevention and treatment of conditions associated with inflammation
KR20100014588A (ko) * 2007-02-27 2010-02-10 제넨테크, 인크. 길항제 ｏｘ40 항체 및 염증성 및 자가면역 질환의 치료에서의 이의 용도
CN101356980B (zh) * 2008-09-04 2011-12-28 中国海洋大学 一种鱼肝脏水解物的制备方法及应用
JP5177901B2 (ja) * 2009-12-02 2013-04-10 株式会社明治 栄養組成物
CN102961404B (zh) * 2012-12-12 2014-05-14 青岛亚博生物科技有限公司 一种从动物器官提取的组合物的衍生物
TWI679014B (zh) * 2013-09-25 2019-12-11 日商志瑞亞新藥工業股份有限公司 肝臟水解物用以製造胰臟機能改善劑之用途
CN103689626A (zh) * 2013-12-30 2014-04-02 徐州绿之野生物食品有限公司 一种营养食品及其加工方法

Also Published As

Publication number Publication date
SG10202108899XA (en) 2021-09-29
WO2018155525A1 (ja) 2018-08-30
TWI794210B (zh) 2023-03-01
CN110198723B (zh) 2024-03-05
CN110198723A (zh) 2019-09-03
TW201834670A (zh) 2018-10-01
KR102608239B1 (ko) 2023-11-30
KR20190119039A (ko) 2019-10-21
JPWO2018155525A1 (ja) 2019-12-12
JP7216966B2 (ja) 2023-02-02

Similar Documents

Publication Publication Date Title
AU2017343793B2 (en) Pyrrolobenzodiazepine conjugates
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
DK3577110T3 (da) 8-oxetan-3-yl-3,8-diazabicyclo[3.2.1]octan-3-yl-substituerede forbindelser som hiv-inhibitorer
MX2020003430A (es) Derivados de 1-bencil-2-imino-4-fenil-5-oxoimidazolidina como inhibidores de proteasa de virus de inmunodeficiencia humana.
AU2018258581A8 (en) RAF-degrading conjugate compounds
EP4368173A3 (en) Pharmaceutical compositions comprising a jak inhibitor
MY195009A (en) Cellular Targeted Active Ingredient Delivery System
EA201992177A1 (ru) Композиции на основе нирапариба
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
MX386292B (es) Aplicador de precision
MX2019010950A (es) Composicion de fotosensibilizador que contiene fenalen-1-ona, compuesto de fenalen-1-ona, asi como su uso.
BR112018002983A2 (pt) composição compreendendo uma lactama e um álcool
EP4700161A3 (en) Direct-to-library methods, systems, and compositions
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
PH12016501252A1 (en) Novel tetrahydropyridopyrimidine compound or salt thereof
MY183068A (en) Pharmaceutical formulation comprising antibody
AU2016351424A8 (en) Pyranodipyridine compound
MX394833B (es) Formulaciones con mejora de la estabilidad.
MA39877A (fr) Formes solides d'un composé pharmaceutiquement actif
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
AU2017277002A1 (en) Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitor
PH12019501451A1 (en) Combination of a mcl-1 inhibitor and a taxane compound, uses and pharmaceuitcal compositions thereof
IN2014MU00859A (ja)
HUE059185T2 (hu) Készítmény, amely e vitaminon vagy észteren alapul bakteriális vagy gomba eredetû biofilmek kezelésére
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.